## Diagnosis: Pemphigus Vulgaris ### Clinical Presentation **Key Point:** Pemphigus vulgaris classically presents with oral mucosal involvement (80–90% of cases) preceding cutaneous manifestations by weeks to months. The buccal mucosa, palate, and gingiva are the most common intraoral sites. **Clinical Pearl:** Flaccid blisters that rupture easily, leaving painful erosions, are characteristic. The blisters are fragile because they form within the epidermis (intraepidermal) rather than at the dermal-epidermal junction. ### Diagnostic Criteria | Feature | Pemphigus Vulgaris | Bullous Pemphigoid | Linear IgA Disease | |---------|-------------------|-------------------|--------------------| | **Blister location** | Intraepidermal | Subepidermal | Subepidermal | | **Blister type** | Flaccid, fragile | Tense, firm | Tense | | **Nikolsky sign** | Positive | Negative | Negative | | **Oral involvement** | Common (80–90%) | Rare (10–20%) | Rare | | **IgG pattern** | Intercellular | Linear (basement membrane) | Linear (basement membrane) | | **Acantholysis** | Present | Absent | Absent | ### Histopathology **High-Yield:** Intraepidermal acantholysis (loss of cell-to-cell adhesion) with the characteristic "tombstone" or "row of tombstones" appearance, where basal cells remain attached to the basement membrane while the suprabasal layer separates. ### Immunofluorescence **Key Point:** Direct immunofluorescence (DIF) shows **intercellular IgG and C3 deposits** in a "chicken-wire" or "honeycomb" pattern around keratinocytes. This is pathognomonic for pemphigus vulgaris. ### Pathophysiology Pemphigus vulgaris is an autoimmune disorder where IgG antibodies target **desmoglein 3** (mucosal dominant type) or both desmoglein 3 and desmoglein 1 (mucocutaneous type). Desmogleins are adhesion molecules in desmosomes, and their disruption leads to acantholysis. ### Nikolsky Sign **Clinical Pearl:** A positive Nikolsky sign (separation of the epidermis with gentle pressure) indicates intraepidermal pathology and is highly specific for pemphigus. It is negative in bullous pemphigoid and other subepidermal blistering disorders. **Mnemonic:** **PEMPHIGUS = Positive Nikolsky + Intraepidermal + Intercellular IgG** ### Treatment Approach 1. Systemic corticosteroids (first-line: prednisolone 1–1.5 mg/kg/day) 2. Steroid-sparing agents: azathioprine, mycophenolate mofetil 3. Topical corticosteroids for oral lesions 4. Rituximab (anti-CD20) for severe or steroid-resistant cases 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.